Malaysia Sees 20 Percent Market Increase In Herbal Medicines
This article was originally published in PharmAsia News
Malaysia expects to total a 20 percent increase in its market for herbal medicines in 2008 as Malaysians come to accept the cures. The chairman and founder of Global Bio-Herbs Economic Forum Council said on the eve of an international forum the potential for herbal sales in Asia is a huge one, and Malaysian producers sitting on the country's rich bio-diversity can expect to reap the benefits. The $3.3 billion in sales expected in 2008 is just a sign of more to come if the industry can take advantage with its production, research and development, clinical trials and marketing, he said. (Click here for more
You may also be interested in...
US FDA looks to post-marketing studies to address elements of the NDA that were not central to its initial swift approval as the first COVID-19 therapy, including pediatric use and the interaction of hepatotoxicity and dose duration.
But advisory committee members caution against including pediatric population in COVID-19 vaccine trials, and one member expresses concern that Pfizer is testing those as young as 12 years of age. Agency is in discussions with product sponsors about enrollment of adolescents.
Public Company Edition: Four health care special purpose acquisition vehicles went public and two others announced mergers, but only one biopharma firm priced an IPO during the week of 19-23 October. Replimune’s $250m offering led recent FOPOs.